Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

Clinical trial NCT04676646 · COMPLETED

Trial details

NCT number: NCT04676646
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperkalaemia Heart Failure With Reduced Ejection Fraction

Start date: 2021-03-08
Primary completion: 2024-07-15
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.